The visibility of tumor antigens can also be rescued by inducing the expression on tumor cells of MHC class II molecules after genetic modification with CIITA, as we have demonstrated in varius experimental tumor models including glioblastoma [51–53]. The gene discussed is CIITA; the disease is glioblastoma.